Wu Qiuling, Lv Tingting, Chen Yan, Wen Lu, Zhang Junli, Jiang Xudong, Liu Fang
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.
Mol Med Rep. 2015 Jul;12(1):1429-34. doi: 10.3892/mmr.2015.3534. Epub 2015 Mar 24.
The toxicities of conventional chemotherapeutic agents to normal cells restrict their dosage and clinical efficacy in acute leukemia; therefore, it is important to develop novel chemotherapeutics, including natural products, which selectively target cancer-specific pathways. The present study aimed to explore the effect of the chemopreventive agent asiatic acid (AA) on the proliferation and apoptotic rate of the leukemia cell line HL-60 and investigated the mechanisms underlying its anti-tumor activity. The effect of AA on the proliferation of HL-60 cells was evaluated using the MTT assay. Annexin V-fluorescein isothiocyanate/propidium iodide double staining followed by flow cytometric analysis as well as Hoechst 33258 staining were used to analyze the apoptotic rate of the cells. Furthermore, changes of survivin, B-cell lymphoma 2 (Bcl-2), myeloid cell leukemia 1 (Mcl-1), extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 expressions were detected by western blot analysis. AA blocked the growth of HL-60 cells in a dose- and time-dependent manner. The IC50-value of AA on HL-60 cells was 46.67 ± 5.08 µmol/l for 24 h. AA induced apoptosis in a dose-dependent manner, which was inhibited in the presence of Z-DEVD-FMK, a specific inhibitor of caspase. The anti-apoptotic proteins Bcl-2, Mcl-1 and survivin were downregulated by AA in a dose-dependent manner. Concurrently, AA inhibited ERK and p38 phosphorylation in a dose-dependent manner, while JNK phosphorylation was not affected. In conclusion, the present study indicated that the p38 and ERK pathways, as well as modulation of Bcl-2 family and survivin proteins were key regulators of apoptosis induced in HL-60 cells in response to AA.
传统化疗药物对正常细胞的毒性限制了其在急性白血病中的剂量及临床疗效;因此,开发新型化疗药物,包括选择性靶向癌症特异性通路的天然产物,具有重要意义。本研究旨在探讨化学预防剂积雪草苷(AA)对白血病细胞系HL-60增殖和凋亡率的影响,并研究其抗肿瘤活性的潜在机制。采用MTT法评估AA对HL-60细胞增殖的影响。采用膜联蛋白V-异硫氰酸荧光素/碘化丙啶双染后进行流式细胞术分析以及Hoechst 33258染色来分析细胞的凋亡率。此外,通过蛋白质免疫印迹分析检测存活素、B细胞淋巴瘤2(Bcl-2)、髓样细胞白血病1(Mcl-1)、细胞外信号调节激酶(ERK)、c-Jun氨基末端激酶(JNK)和p38表达的变化。AA以剂量和时间依赖性方式阻断HL-60细胞的生长。AA作用24小时对HL-60细胞的IC50值为46.67±5.08μmol/l。AA以剂量依赖性方式诱导凋亡,在存在半胱天冬酶特异性抑制剂Z-DEVD-FMK的情况下这种凋亡受到抑制。抗凋亡蛋白Bcl-2、Mcl-1和存活素被AA以剂量依赖性方式下调。同时,AA以剂量依赖性方式抑制ERK和p38磷酸化,而JNK磷酸化未受影响。总之,本研究表明p38和ERK通路以及Bcl-2家族和存活素蛋白的调节是AA诱导HL-60细胞凋亡的关键调节因子。